Business Wire

The Trust Gap: Companies value digital trust but little progress is being made to implement it

29.5.2024 17:46:00 EEST | Business Wire | Press release

Share

As organisations purse digital transformation, they urgently need to prioritise digital trust to achieve their goals and prepare for future market opportunities, legislation, and regulatory compliance. New research from ISACA, the leading global professional association helping individuals and organisations in their pursuit of digital trust, reveals critical gaps in organisational strategies regarding digital trust.

The ISACA State of Digital Trust 2024 report finds that 77% of respondents agree that digital trust is crucial to digital transformation and 82% say digital trust will grow in importance over the next five years. Despite this recognition, almost three quarters (71%) report that their organisation provides no staff training on digital trust and only 21% of organizations are planning to increase their budget for digital trust.

Most (76%) business and IT professionals believe digital trust is relevant to their organisation and 65% say it is important that organisations be independently graded on digital trust practices, with the results made publicly available. ISACA defines digital trust as the confidence in the integrity of the relationships and transactions between providers and consumers within a digital ecosystem and is a key indicator of an organisation’s security credentials.

Despite recognising its relevance and importance, three quarters (75%) of respondents are either unsure or not fully aware of what improving digital trust requires in practice. A similar number (77%) report that their organisations do not currently measure the maturity of their digital trust practices or are unsure if they do.

Chris Dimitriadis, Chief Global Strategy Officer at ISACA, said: “It’s encouraging that businesses continue to recognise the importance of digital trust, not just for business sustainability, security, and profitability, but for building long-term consumer trust. Yet more needs to be done to truly achieve high levels of digital trust, which starts with measuring current levels to establish a benchmark and create a maturity plan.”

39% of organisations admit they are experiencing more cyberattacks, and 15% are suffering from more privacy breaches compared to a year ago. And this is only going to get worse if businesses don’t prioritise digital trust. Respondents recognise that organisations with low digital trust are more likely to see a reputation decline (64%), suffer from more cybersecurity incidents (58%), experience more privacy breaches (57%) and even lose customers (54%). The survey reveals that the biggest obstacles to achieving high levels of digital trust include a lack of staff skills and training (50%), lack of buy-in from leadership (42%), and insufficient processes and governance practices (32%).

Dimitriadis adds: “It is not down to business leaders alone to lead the charge - digital trust practices should be implemented and aligned across all departments to truly succeed. Our survey has found that many businesses are unsure on what improving digital trust requires in practice, but working with a trusted partner who can provide a step-by-step framework and assist in digital trust training can set the business on the right path to success and security.”

Leveraging Tools and Frameworks to Advance Trust

According to the survey, only 15 percent of respondents’ organizations currently use a framework for their digital trust practices, but almost half (46 %) of respondents believe it is extremely/very important for an organisation to have a digital trust framework. ISACA recently launched its Digital Trust Ecosystem Framework (DTEF), a comprehensive digital trust resource with indicators and controls that can be used and customised for the needs of all organisations. The DTEF roadmap and implementation guides provide a clear understanding of how organisations can attain the level of digital trust that fits their business models, strategies, and goals.

The top three benefits of using a framework include saving time and effort, enabling benchmarking with other organisations in a cost-efficient way, and providing added credibility and third-party validation in support of budget and staff requests.

Notes to Editors

All figures are based on fieldwork conducted by ISACA between 12th and 30th January 2024, amongst a total of 1,161 business and IT professionals in Europe. In total, ISACA surveyed 5,870 business and IT professionals worldwide.

About ISACA

ISACA® (www.isaca.org) is a global community advancing individuals and organizations in their pursuit of digital trust. For more than 50 years, ISACA has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its 180,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through the ISACA Foundation, ISACA supports IT education and career pathways for underresourced and underrepresented populations.

Twitter: www.twitter.com/ISACANews
LinkedIn: www.linkedin.com/company/isaca
Facebook: www.facebook.com/ISACAGlobal
Instagram: www.instagram.com/isacanews

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Firstlight Group
+44 7960 079 643, isacateam@firstlightgroup.io

ISACA
Esther Almendros, +34 692 669 772, ealmendros@isaca.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye